Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Keros Therapeutics (KROS) Tax Rate (2020 - 2025)

Keros Therapeutics (KROS) has disclosed Tax Rate for 4 consecutive years, with 6.06% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate rose 672.0% year-over-year to 6.06%, compared with a TTM value of 5.31% through Dec 2025, up 547.0%, and an annual FY2025 reading of 5.31%, up 547.0% over the prior year.
  • Tax Rate was 6.06% for Q4 2025 at Keros Therapeutics, down from 16.36% in the prior quarter.
  • Across five years, Tax Rate topped out at 16.36% in Q3 2025 and bottomed at 40.46% in Q4 2021.
  • Average Tax Rate over 3 years is 0.72%, with a median of 3.12% recorded in 2021.
  • The sharpest move saw Tax Rate plummeted -174bps in 2021, then surged 672bps in 2025.
  • Year by year, Tax Rate stood at 40.46% in 2021, then skyrocketed by 98bps to 0.66% in 2024, then soared by 1024bps to 6.06% in 2025.
  • Business Quant data shows Tax Rate for KROS at 6.06% in Q4 2025, 16.36% in Q3 2025, and 6.75% in Q2 2025.